MD20060037A - Method of treating the acute viral hepatitis C - Google Patents

Method of treating the acute viral hepatitis C

Info

Publication number
MD20060037A
MD20060037A MDa20060037A MD20060037A MD20060037A MD 20060037 A MD20060037 A MD 20060037A MD 20060037 A MD20060037 A MD 20060037A MD 20060037 A MD20060037 A MD 20060037A
Authority
MD
Moldova
Prior art keywords
β
viral hepatitis
acute viral
treating
method
Prior art date
Application number
MDa20060037A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Константин СПЫНУ
Виктор ПЫНТЯ
Лилия КОЖУХАРЬ
Павел КИНТЯ
Игорь СПЫНУ
Original Assignee
Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова filed Critical Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова
Priority to MDa20060037A priority Critical patent/MD20060037A/en
Publication of MD20060037A publication Critical patent/MD20060037A/en

Links

Abstract

The invention refers to medicine, namely to the infectious diseases.Summary of the invention consists in that treatment of acute viral hepatitis C includes the symptomatic therapy and additional administration of the immunomodulatory and antiviral remedy 5α-furostan-3β,22,26-triol-3[O-β- galactopyranosyl(1→2)-β-D-glucopyranosyl)(1→4)-β-D-galactopyranosyl]-26-O-β-D-glucopyranoside (pacovirin) during 10 days, beginning with the first day of clinical manifestation or hospitalization, for 50 mg, 3 times a day, per os.
MDa20060037A 2006-01-24 2006-01-24 Method of treating the acute viral hepatitis C MD20060037A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDa20060037A MD20060037A (en) 2006-01-24 2006-01-24 Method of treating the acute viral hepatitis C

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDa20060037A MD20060037A (en) 2006-01-24 2006-01-24 Method of treating the acute viral hepatitis C

Publications (1)

Publication Number Publication Date
MD20060037A true MD20060037A (en) 2007-07-31

Family

ID=38331510

Family Applications (1)

Application Number Title Priority Date Filing Date
MDa20060037A MD20060037A (en) 2006-01-24 2006-01-24 Method of treating the acute viral hepatitis C

Country Status (1)

Country Link
MD (1) MD20060037A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8809265B2 (en) 2011-10-21 2014-08-19 Abbvie Inc. Methods for treating HCV
US8853176B2 (en) 2011-10-21 2014-10-07 Abbvie Inc. Methods for treating HCV

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD670G2 (en) * 1996-05-08 1997-08-31 Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova Remedy with immunomodulator activity
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B
MD2053C2 (en) * 2001-07-10 2003-07-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Remedy with interferon inducing action
MD2549G2 (en) * 2003-07-18 2005-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the chronic viral hepatitis C
MD2700C2 (en) * 2004-07-01 2005-10-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD670G2 (en) * 1996-05-08 1997-08-31 Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova Remedy with immunomodulator activity
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B
MD2053C2 (en) * 2001-07-10 2003-07-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Remedy with interferon inducing action
MD2549G2 (en) * 2003-07-18 2005-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the chronic viral hepatitis C
MD2700C2 (en) * 2004-07-01 2005-10-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Process for obtaining of 5a-furostan-3B,22,26-triol-3-[O-B-D-glucopyranosyl (1→2)-B-D-glucopyranosyl(1→4)-B-D-galactopyranosyl]-26-O-B-D-glucopyranoside (pacoverine)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Амипресс", 1999г. <http:// http://www.gepatitu.net/15/1508.htm#13> *
Соринсон С. Н. Вирусные гепатиты. Тезa, Санкт-Петербург, 1998, с. 231-244 *
Энциклопедический Словарь "Вирусные Гепатиты" (Второе издание) М.С. Балаян, М.И. Михайлов, Москва, издательство *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8680106B2 (en) 2011-10-21 2014-03-25 AbbVic Inc. Methods for treating HCV
US8685984B2 (en) 2011-10-21 2014-04-01 Abbvie Inc. Methods for treating HCV
US8809265B2 (en) 2011-10-21 2014-08-19 Abbvie Inc. Methods for treating HCV
US8853176B2 (en) 2011-10-21 2014-10-07 Abbvie Inc. Methods for treating HCV
US8969357B2 (en) 2011-10-21 2015-03-03 Abbvie Inc. Methods for treating HCV
US8993578B2 (en) 2011-10-21 2015-03-31 Abbvie Inc. Methods for treating HCV
US9452194B2 (en) 2011-10-21 2016-09-27 Abbvie Inc. Methods for treating HCV

Similar Documents

Publication Publication Date Title
TWI389693B (en) Extended therapeutic effect ocular implant treatments
RU2482119C2 (en) Crystalline forms and rapamycin analogues
AR058133A1 (en) Method of treatment and / or prevention of infection in infants delivered via caesarean
WO2006050250A3 (en) Dose forms comprising vx-950 and their dosage regimen
WO2007062107A3 (en) Immunostimulatory oligoribonucleotides
NO20092179L (en) Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
WO2010045656A3 (en) Novel sglt2 inhibitor dosage forms
SG161307A1 (en) Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
WO2004112711A3 (en) Oral extended-release composition
SG170119A1 (en) Nutritional composition comprising indigestible oligosaccharides
NO20053782L (en) Treatment of cancer with 2-deoxyglucose
EP2444072A3 (en) Non-mucoadhesive film dosage forms
TW201321002A (en) Methods for treating HCV
WO2005023083A3 (en) Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
NO20070702L (en) Combination therapy for non-hematologic malignancy using anti-OGF-1R antibody
WO2000037110A3 (en) Ribavirin-pegylated interferon alfa induction hcv combination therapy
IL197316A (en) Buprenophine-wafer for drug substitution therapy
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
IL188182A (en) Pyridazine derivatives, pharmaceutical compostions comprising them, process for their preparation and use thereof in the preparation of medicaments for the treatment and prophylaxis of diabetes
NO20092585L (en) Compounds and pharmaceutical compositions for treating viral infections
WO2007117509A3 (en) High delivery rates for lipid based drug formulations, and methods of treatment thereof
CO5550426A2 (en) Novel therapeutic method
MX2013003634A (en) Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases.
CA2563609A1 (en) Pharmaceutical compositions for acute glucocorticoid therapy
NZ572049A (en) Method for treatment of constipation-predominant irritable bowel syndrome

Legal Events

Date Code Title Description
FC9A Refusal of application